BONE GIANT CELL TUMOUR

This adverse event was reported 387 times

These drugs are most commonly taken by patients reporting BONE GIANT CELL TUMOUR:

# Drug Count
0 DENOSUMAB 309
1 CALCIUM 94
2 ERGOCALCIFEROL 75
3 ADALIMUMAB 10
4 ASPIRIN 6
5 ASPIRIN 325 MG 6
6 ASPIRIN 81 MG 6
7 METHYLPREDNISOLONE 6
8 INFLIXIMAB 5
9 INTERFERON BETA-1A 5
See all common drugs associated with BONE GIANT CELL TUMOUR

BONE GIANT CELL TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 1169 HYDROGEN PEROXIDE SPRAY 1 0.0032
1 HYDROGEN PEROXIDE 1 0.0030
2 ERGOCALCIFEROL 75 0.0025
3 DENOSUMAB 309 0.0015
4 CHROMIC CHLORIDE 1 0.0012
5 SELENIUM 2 0.0005
6 METHYLCELLULOSE 1 0.0004
7 ZINC SULFATE INJECTION, 1 0.0003
8 ZINC SULFATE INJECTION 1 0.0003
9 CALCITONIN SALMON 1 0.0003
See all drugs enriched for association with BONE GIANT CELL TUMOUR

BONE GIANT CELL TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 75 0.0025
1 RANK Ligand Inhibitor [EPC] 309 0.0015
2 Calcium [EPC] 94 0.0006
3 Calcitonin [EPC] 1 0.0003
4 Recombinant Human Growth Hormone [EPC] 3 0.0001
5 Potassium-sparing Diuretic [EPC] 1 0.0001
6 Human Immunoglobulin G [EPC] 1 0.0000
7 General Anesthetic [EPC] 2 0.0000
8 Interleukin-23 Antagonist [EPC] 4 0.0000
9 Arteriolar Vasodilator [EPC] 3 0.0000
See all drug classes enriched for association with BONE GIANT CELL TUMOUR